Unique ID issued by UMIN | UMIN000005094 |
---|---|
Receipt number | R000006029 |
Scientific Title | A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate |
Date of disclosure of the study information | 2011/02/16 |
Last modified on | 2014/02/19 17:20:58 |
A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate
A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate
A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate
A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate
Japan |
colorectal cancer, colorectal polyp
Gastroenterology | Radiology | Laboratory medicine |
Malignancy
NO
To compare the efficacy, tolerability, and safety of a new polyethylene glycol lavage solution plus contrast medium and Mosapride Citrate Hydrate (PEG-CM) with a PEG-C (without Mosapride Citrate Hydrate ) as bowel preparation before CT colonography.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
PEG-C versus PEG-C + Mosapride Citrate Hydrate for bowel preparation before CT colonography to be asscessed by the amount of residual fluid.
Comparative adherence of patients to PEG-C preparation and PEG-C + Mosapride Citrate Hydrate preparation.
Frequency and nature of any adverse events.
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Diagnosis
Medicine |
Polyethylene glycol lavage solution plus contrast medium (PEG-C) preparation before CT colonography
Polyethylene glycol lavage solution plus contrast medium and Mosapride Citrate Hydrate (PEG-CM) preparation before CT colonography
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients who are eligible for optical colonoscopy.
2) Aged 20 years or older.
3) Major functions of organs of the subjects are in a good condition.
4) Signed informed consent forms are obtained by the patients.
1) Serious medical conditions that may increase the risk of optical colonoscopy or are so severe that screening would have no benefit.
2) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon.
3) Evidence of an increased risk in carrying out bowel preparation or CTC exams.
4) Possibility of pregnancy.
5) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial.
6) Iodine hypersensitivity.
7) Severe thyroid disease.
8) Claustrophobia.
9) Severe deafness.
10) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.
100
1st name | |
Middle name | |
Last name | Tetsuro Honda, Takahiro Yasaka |
Kamigoto Hospital
Department of Internal Medicine, Department of Surgery
1549-11, Aokatago, Shin-Kamigoto, Minami-matsuura, Nagasaki, Japan, 857-4404
0959-52-3000
tetsupeacevo@yahoo.co.jp
1st name | |
Middle name | |
Last name | Tetsuro Honda |
Kamigoto Hospital
Kamigoto Hospital
1549-11, Aokatago, Shin-Kamigoto, Minami-matsuura, Nagasaki, Japan, 857-4404
0959-52-3000
tetsupeacevo@yahoo.co.jp
Kamigoto Hospital
None
Self funding
NO
上五島病院(長崎県)
2011 | Year | 02 | Month | 16 | Day |
Unpublished
Open public recruiting
2009 | Year | 08 | Month | 02 | Day |
2009 | Year | 08 | Month | 01 | Day |
2011 | Year | 09 | Month | 01 | Day |
2013 | Year | 09 | Month | 01 | Day |
2013 | Year | 10 | Month | 30 | Day |
2013 | Year | 12 | Month | 15 | Day |
2011 | Year | 02 | Month | 16 | Day |
2014 | Year | 02 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006029